title: [Percutaneous therapy of malignant obstructive jaundice using expandable metal stents: a prospective study of 92 patients].
abstract: OBJECTIVE
  To evaluate the clinical efficiency of percutaneously placed metallic stents in patients with malignant biliary obstruction.
  
  
  METHODS
  In a prospective study 92 consecutive patients with malignant biliary obstruction were treated percutaneously with expandable metallic stents. Technical and clinical parameters during the procedure and regular follow-up were evaluated.
  
  
  RESULTS
  Technical and clinical success rates were 100 and 91% respectively. During stent implantation we observed no severe complications. 30-day morbidity and mortality were 12 and 13% respectively. Late complications occurred in 35%, in 20.7% due to reocclusion of the bile ducts which was treated successfully in 17/19 patients. 75% of patients benefited from the procedure. Primary and secondary patency were 79.3 and 97.8%, respectively.
  
  
  CONCLUSIONS
  Percutaneous transhepatic implantation of expandable metallic stents is a reliable and safe therapy for malignant jaundice and has a definite positive impact on the patients quality of life.
authors.affiliation: Abteilung Radiodiagnostik der Universitätsklinik Heidelberg.
authors.forename: T
authors.initials: T
authors.lastname: Roeren
authors.forename: W
authors.initials: W
authors.lastname: Tonn
authors.forename: G M
authors.initials: GM
authors.lastname: Richter
authors.forename: H J
authors.initials: HJ
authors.lastname: Brambs
authors.forename: G
authors.initials: G
authors.lastname: Kauffmann
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014670:Ampulla of Vater; D000704:Analysis of Variance; D001650:Bile Duct Neoplasms / Q000150:complications; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000150:complications; D002779:Cholestasis / Q000209:etiology* / Q000601:surgery*; D003138:Common Bile Duct Neoplasms / Q000150:complications; D004322:Drainage; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D005706:Gallbladder Neoplasms / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000150:complications; D011446:Prospective Studies; D012044:Regression Analysis; D015607:Stents / Q000009:adverse effects; D013997:Time Factors